Projects per year
Personal profile
Biography
Dr Louisa Picco (MPH, PhD) is a NHMRC Emerging Leader Research Fellow at the Monash Addiction Research Centre in Melbourne. Her research areas of interest include identifying and responding to prescription opioid related risks and harms, particularly through the implementation of prescription drug monitoring programs. She also has extensive experience in mental health research, and mental health and substance use related stigma.
Dr Picco has published over 90 peer-reviewed publications which have been cited 1677 (Scopus) to 2907 (Google) times. H-index =23 (Scopus) to 29 (Google), i10-index =61. She has been awards over $790,000 in research funding as a Primary Investigator in Australia. In addition, she has also been a Co-Investigator in >$8M in research funding in Singapore.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Addiction
- prescription drug
- Opioid
- Mental Health
- Stigma
- Drug Addiction
- Public Health
- Drug policy
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Optimising the investment in real-time prescription drug monitoring
National Health and Medical Research Council (NHMRC) (Australia)
1/01/23 → 31/12/27
Project: Research
-
Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply
Tse, W., Djordjevic, F., Borja, V. A., Picco, L., Lam, T., Olsen, A., Larney, S., Dietze, P. M. & Nielsen, S., Feb 2022, In: International Journal of Drug Policy. 100, 9 p., 103513.Research output: Contribution to journal › Review Article › Research › peer-review
10 Citations (Scopus) -
Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
Picco, L., Lam, T., Xia, T. & Nielsen, S., 2022, (Accepted/In press) In: International Journal of Clinical Pharmacy. 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment
Picco, L., Sanfilippo, P., Xia, T., Lam, T. & Nielsen, S., Nov 2022, In: International Journal of Drug Policy. 109, 9 p., 103856.Research output: Contribution to journal › Article › Research › peer-review
-
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
Nielsen, S., Picco, L., Murnion, B., Winters, B., Matheson, J., Graham, M., Campbell, G., Parvaresh, L., Khor, K. E., Betz-Stablein, B., Farrell, M., Lintzeris, N. & Le Foll, B., 2022, (Accepted/In press) In: Neuropsychopharmacology. 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access7 Citations (Scopus) -
A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for Medication Assisted Treatment for Opioid Dependence: Protocol for the EPIC-MATOD study
Nielsen, S., Cheetham, A., Jackson, J., Lord, S., Petrie, D., Jacka, D., Picco, L. & Morgan, K., 18 Nov 2021, (Accepted/In press) In: Research in Social and Administrative Pharmacy. 8 p.Research output: Contribution to journal › Article › Other › peer-review
1 Citation (Scopus)